MedPath

ARGX-112

Generic Name
ARGX-112

A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

Phase 2
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: Placebo
First Posted Date
2023-06-28
Last Posted Date
2025-05-02
Lead Sponsor
LEO Pharma
Target Recruit Count
250
Registration Number
NCT05923099
Locations
🇬🇧

LEO Investigational Site, Walsall, United Kingdom

🇺🇸

LEO investigational site, Indianapolis, Indiana, United States

🇺🇸

LEO investigational Site, New Albany, Indiana, United States

and more 1 locations

A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD

Phase 2
Completed
Conditions
Atopic Dermatitis
Interventions
First Posted Date
2022-07-22
Last Posted Date
2025-03-11
Lead Sponsor
LEO Pharma
Target Recruit Count
13
Registration Number
NCT05470114
Locations
🇦🇹

LEO Investigational Site, Wien, Austria

A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects

Phase 1
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: LEO 138559 Placebo
First Posted Date
2021-10-29
Last Posted Date
2025-02-24
Lead Sponsor
LEO Pharma
Target Recruit Count
24
Registration Number
NCT05099133
Locations
🇺🇸

LEO Investigational Site, Los Angeles, California, United States

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Phase 2
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: LEO 138559 placebo
First Posted Date
2021-06-10
Last Posted Date
2025-03-13
Lead Sponsor
LEO Pharma
Target Recruit Count
58
Registration Number
NCT04922021
Locations
🇵🇱

LEO Pharma nvestigational Site, Rzeszów, Poland

🇵🇱

LEO Pharma Investigational Site, Wrocław, Poland

Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis

Phase 1
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: LEO 138559 placebo
First Posted Date
2018-05-02
Last Posted Date
2025-02-24
Lead Sponsor
LEO Pharma
Target Recruit Count
47
Registration Number
NCT03514511
Locations
🇬🇧

Investigational site, Liverpool, United Kingdom

🇬🇧

LEO Pharma investigational site, Manchester, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath